Life-Saving
Diagnostic Solutions
FOR A HEALTHIER TOMORROW
TOLLOVID: NATURAL IMMUNE SUPPORT WITH 3CL PROTEASE INHIBITORS
Buy Now
TOLLOVIR:
A PHASE 2/3 READY DRUG CANDIDATE FOR COVID-19
Learn More
VIDESSA:
BREAST CANCER DIAGNOSTIC TO IMPROVE WOMEN'S HEALTH
Learn More
GROUND-BREAKING DIAGNOSTICS IN DEVELOPMENT
Learn More
BOTANICAL MANUFACTURING FOR CBD AND SUPPLEMENTS
Learn More
LARGE VOLUME COVID-19 TESTING FOR CLIA LABS
Learn More
Diagnostic Testing Solutions for the Immune System
COVID, Cancer & Alzheimer’s
Lab Solutions
Our focus on automation has created a commercial infrastructure able to deploy integrated solutions for labs looking to scale services for their core clients.
Provista Diagnostics: CLIA/CAP Lab >
COVID Testing Solutions >
R&D Pipeline
Evidence suggests that blood-based tests are the future of cancer screening. Our TBIA platform represents a cost-effective, scalable, and patient-friendly screening practice for cancer detection.
Videssa® Breast: Cancer Blood Test >
LymPro™: Alzheimer's Blood Test >
TolloTest™: 3CL Protease Test >
TBIA: AI Cancer Platform >
Protease Inhibitors
Todos has acquired exclusive distribution rights to the immune boosting, dietary supplement Tollovid™ and is developing Tollovir™, a highly potent 3CL protease inhibitor as a COVID-19 antiviral.